Products

ELTEX MED PP Homopolymer 100-MG25

    • Product Name: ELTEX MED PP Homopolymer 100-MG25
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 832816
    Density 0.905 g/cm³
    Melt Flow Rate 230 C 2 16 Kg 25 g/10 min
    Tensile Stress At Yield 36 MPa
    Elongation At Yield 8%
    Flexural Modulus 1400 MPa
    Tensile Modulus 1600 MPa
    Charpy Notched Impact Strength 23 C 2.5 kJ/m²
    Charpy Notched Impact Strength 20 C 1.5 kJ/m²
    Rockwell Hardness R 100
    Vicat Softening Temperature A50 155 °C
    Heat Deflection Temperature 0 45 Mpa 90 °C
    Melting Temperature 165 °C

    As an accredited ELTEX MED PP Homopolymer 100-MG25 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing ELTEX MED PP Homopolymer 100-MG25 is supplied in 25 kg polyethylene-lined paper bags, ensuring product purity and safe handling.
    Container Loading (20′ FCL) ELTEX MED PP Homopolymer 100-MG25 is loaded in a 20′ FCL as 25 kg bags on pallets, shrink-wrapped and protected from moisture.
    Shipping ELTEX MED PP Homopolymer 100-MG25 ships as non-hazardous polypropylene resin pellets in sealed multi-layer bags or bulk containers. Products should be protected from moisture, direct sunlight, and excessive heat during transport. Standard dry cargo containers or covered vehicles are suitable, with careful handling to prevent bag damage and contamination.
    Storage Store ELTEX MED PP Homopolymer 100-MG25 in a clean, dry, well-ventilated area away from direct sunlight, heat sources, and open flames. Keep in its original sealed packaging to prevent contamination and moisture uptake. Maintain room temperature and avoid prolonged exposure to high temperatures. Ensure proper labeling and separate from incompatible materials.
    Shelf Life Shelf life is indefinite when stored in original, unopened packaging under dry, cool conditions away from direct sunlight.
    Application of ELTEX MED PP Homopolymer 100-MG25

    Thin-wall injection molding of disposable syringe barrels from ELTEX MED 100-MG25 requires a melt temperature confined to a 220–250 °C band, with excursions above 255 °C triggering rapid molecular weight degradation manifested as yellowing and a loss of burst strength below the ISO 7886-1:2017, Annex B threshold of 1.5× nominal capacity. Barrel molds—typically constructed from hardened stainless steel with 0.005–0.010 mm core-cavity clearances—are gated via valve-controlled hot runner systems delivering shot weights from 2.5 g (1 mL syringe) to 12 g (5 mL syringe) within injection times of 0.12–0.35 s. Clamp force is calculated at 4–6 kN/cm² of projected area to prevent flash along the parting line, a critical hazard when the material’s 25 g/10 min MFR (ISO 1133-1:2022, 230 °C/2.16 kg) couples with low-viscosity melt behavior at the upper temperature limit. Mold surface temperature is thermostatically regulated to 15–30 °C via turbulent-flow water circuits; deviation beyond 35 °C prolongs cycle time and raises haze above 3% as measured per ASTM D1003. Post-molding, barrels are conveyed through a Class 8 (ISO 14644-1) cleanroom environment and subjected to ethylene oxide (EtO) sterilization per ISO 11135:2014 or gamma irradiation at 25–40 kGy per ISO 11137-1:2006. The formulation addition rate for clarifying agents is 0.15–0.30 wt% of a sorbitol-based masterbatch dosed at the hopper via gravimetric feeder; exceeding 0.35 wt% induces plate-out on mold venting surfaces and requires manual cleaning every 8,000–12,000 cycles. Compliance with USP <88> Class VI, ISO 10993-4 (hemolysis), -5 (cytotoxicity), and -10 (intracutaneous reactivity) is mandatory for the finished sterile hypodermic syringe.

    Are Nucleating Agent Masterbatches Mandatory for Class VI Microcentrifuge Tube Transparency?

    Clarity requirements for 0.2 mL to 2.0 mL polypropylene microcentrifuge tubes, defined by light transmittance ≥ 88% at 550 nm through a 1 mm wall section (ASTM D1003), are achievable with ELTEX MED 100-MG25 only when a controlled fraction of nucleating additive is introduced. Without nucleation, the base polypropylene homopolymer crystallizes into spherulites of 20–50 μm diameter during the cooling stage, scattering visible light and producing a milky appearance incompatible with photometric recovery assays. A sorbitol acetal clarifier added at 0.10–0.20 wt%—predispersed on a PP carrier resin to a 5% active concentrate—reduces spherulite size below the wavelength of visible light while raising the crystallization onset temperature by 8–12 °C, thereby shortening mold residence time by approximately 1.2–1.8 s in a 48‑cavity hardened steel tool. The manufacturing line employs an all-electric injection molding machine (Engel e‑mac 140/80) with a 22 mm diameter barrier screw and an L/D ratio of 22:1; melt temperature is profiled in three zones progressing from 210 °C to 235 °C at the nozzle. Mould temperature is held at 25 ± 3 °C using direct-cooled beryllium-copper core inserts to ensure dimensional tolerance of ±0.02 mm on the snap-cap sealing lip. End-use products—conical‑bottom and skirted microtubes for PCR, centrifugation, and serological storage—must withstand relative centrifugal forces of 20,000 × g for 20 min without stress cracking; this performance is verified in‑house per a protocol derived from DIN 58933-1, with visual inspection under 10 × magnification following autoclave preconditioning at 121 °C for 30 min. Biocompatibility documentation covers ISO 10993-5, -10, and -11 endpoints, with the resin lot‑specific certificate referencing the FDA Drug Master File associated with ELTEX MED grades.

    Diagnostic Rapid Test Cassette Dimensional Stability and Background Fluorescence

    Lateral‑flow immunoassay cassettes molded from ELTEX MED 100-MG25 serve as the structural housing for nitrocellulose test strips and must exhibit in‑mold shrinkage not exceeding 1.2–1.5% in the flow direction and 1.0–1.3% transversely, measured per ISO 294-4 on a 60 × 60 × 2 mm plaque. The cassette comprises a top and bottom half ultrasonically welded along a continuous 1.5‑mm‑wide energy director; a flatness deviation of more than 0.10 mm across the 80‑mm length of the part leads to incomplete fusion and allows moisture ingress that degrades the conjugated antibody line. Molding is executed on a hybrid injection press with 1,200 kN clamping force, using a two‑cavity family mold fitted with conformal cooling channels that maintain cavity surface temperature at 35 ± 2 °C, as validated by DR 5018 thermal imaging. No colorants, optical brighteners, or slip agents are introduced into the feedstock; the material is processed in its neat form because even 0.005 wt% of residual bis‑benzoxazole‑type brightener—a common contaminant in recycled PP streams—generates background fluorescence under 365‑nm UV excitation that elevates the limit of blank above 0.2 ng/mL for troponin I assays. Post‑moulding, cassettes are packaged in anti‑static polyethylene bags within an ISO 7 cleanroom and undergo bioburden testing per ISO 11737‑1. The assembled device is regulated as an in‑vitro diagnostic medical device under Regulation (EU) 2017/746 and meets the biocompatibility requirements of ISO 10993‑1:2018 for surface‑contacting devices with <24‑hour exposure duration.

    Processing window and mandatory compliance standards across ELTEX MED 100-MG25 application scenarios
    Scenario Melt temp. (°C) Mould temp. (°C) Injection pressure (MPa) Key normative reference(s)
    Syringe barrel (1–5 mL) 220–250 15–30 80–130 ISO 7886-1:2017, USP <88> VI
    Microcentrifuge tube (0.2–2.0 mL) 210–235 22–28 90–140 DIN 58933-1, ISO 10993-5/-10/-11
    Rapid test cassette 230–245 33–37 60–100 EU 2017/746, ISO 10993-1
    Pipette tip (10–1000 µL) 225–245 8–18 120–160 ISO 8655-2:2002, ISO 11137-1
    Pharmaceutical blister 210–240 (extrusion), 150–165 (forming) 15–25 (sheet calibrator) N/A (thermoforming) Ph.Eur. 3.1.3, USP <661.1>
    Conical centrifuge tube (15/50 mL) 215–235 20–30 80–110 ISO 13485:2016, USP <88> VI

    When pipette tip wall concentricity tolerances must remain below 0.05 mm across a 64‑cavity hot‑runner stack mold operating on a 3.2‑second dry‑cycle clock, ELTEX MED 100-MG25 demands a melt‑flow front velocity at the gate exceeding 350 mm/s to avoid hesitation lines in the tapered draw zone. The nozzle temperature is set at 240 °C, with the manifold and drop temperatures individually trimmed within ±2 °C by pulse‑width‑modulated heaters; any disparity larger than 4 °C between adjacent cavities results in a coefficient of variation for the tip orifice diameter approaching 3%, exceeding the ISO 8655-2:2002 specification for liquid handling precision. Oil‑free, medical‑grade chillers cool the mould to 10–12 °C, generating a rapid frozen‑skin layer that suppresses sink marks in the 0.35‑mm‑thick tip wall adjacent to an 8‑mm‑diameter hub. A proprietary anti‑static masterbatch—compounded at 0.5–1.0 wt% using a non‑ethoxylated amide migrating agent—reduces surface resistivity to 10¹²–10¹³ Ω/sq (IEC 61340-2-3), minimizing retained droplet volume to less than 0.2 µL for a 200‑µL tip when tested per the gravimetric method of ISO 8655‑6. Post‑processing, the tips are racked in flow‑wrapped polyethylene trays and sterilized by gamma irradiation at 25–40 kGy, with oxidation products monitored via FTIR spectroscopy; an absorbance peak at 1720 cm⁻¹ exceeding 0.05 AU indicates chain scission and prompts rejection of the sub‑lot. Regulatory submission for a pipette tip as a laboratory consumable relies on ISO 13485:2016 quality management harmonized with 21 CFR Part 820, supported by biological evaluation per ISO 10993‑5 (MEM elution assay).

    Blister Cavity Thermoforming and Drug-Contact Compliance

    ELTEX MED 100-MG25 is extruded as a 250–400 µm‑thick sheet on a single‑screw extruder (D = 45 mm, L/D = 30:1) with a barrier‑flight design to capture unmetled gel particles larger than 50 µm. Die‑head temperature is maintained at 225 °C, and a polished three‑roll stack with roll temperatures of 20 °C (top) and 18 °C (bottom) controls sheet crystallinity within 40–50% as determined by DSC heat‑of‑fusion integration (ISO 11357-3). The sheet is subsequently heated by ceramic‑panel radiant heaters to a surface temperature of 150–160 °C and drawn into water‑cooled aluminum forming tools under vacuum (‑0.8 bar gauge) to produce cavities for tablets or capsules. Because the polypropylene homopolymer lacks an intrinsic elastomeric phase, the draw ratio is restricted to 3:1 to prevent corner thinning beyond 60 µm—a thickness below which oxygen transmission rate rises above 800 cm³/(m²·day·bar) (ASTM D3985), compromising moisture‑sensitive APIs. No plasticizers or processing aids are added; a titanium dioxide masterbatch (TiO₂, rutile grade) may be incorporated up to 2.0 wt% for opacification of light‑protected drugs, accompanied by a pharmaceutical‑grade antistatic additive at 0.1–0.3 wt% to facilitate sheet stacking. The formed blister is heat‑sealed to an aluminium foil lidding at 180 °C under a dwell time of 0.8 s. Conformity to Ph.Eur. 3.1.3 (Polyolefins) and USP <661.1> (Plastic Packaging Systems for Pharmaceutical Use) is verified through total organic carbon (TOC) and UV absorption of purified water extracts following 2‑hour reflux at 121 °C. Ethylene oxide sterilization (ISO 11135) is employed when the lidded blister serves as a primary packaging for sterile solid dose forms.

    What Limits the Maximum RCF Rating of PP Homopolymer Conical Centrifuge Tubes?

    Conical‑bottom centrifuge tubes of 15 mL and 50 mL nominal capacity produced from ELTEX MED 100-MG25 depend on a carefully managed internal stress profile to achieve consistent relative centrifugal force ratings of 5,000–8,000 × g at 20 °C. The limiting factor is the low‑temperature brittleness characteristic of the homopolymer; below 0 °C the notched Izod impact strength, clocking 3.5 kJ/m² at 23 °C (ISO 180/A), rapidly declines to under 1.5 kJ/m², making tubes susceptible to radial crack initiation at the conical frustum‑wall junction when centrifuged at 4 °C in refrigerated rotors. Molding is performed on a hydraulic clamping press with a 1,800 kN force capability, using a multi‑cavity tool (4+4) with sequential valve gating that fills the thick‑walled conical section (2.8 mm) before the thinner cylindrical wall (1.2 mm) to eliminate an asymmetric weld line that could nucleate a stress concentrator. A sorbitol‑based clarifier masterbatch added at 0.10–0.20 wt% refines the crystal morphology, improving impact resistance by approximately 15% over unclarified resin, as documented in the supplier’s medical‑device application note. When fabricated as a graduated, printed tube with a polyethylene screw cap, the assembly is subjected to lot‑release testing: 100% bubble‑leak test under ‑0.6 bar vacuum and burst pressure threshold ≥ 1.0 bar. Biocompatibility follows the full USP <88> Class VI protocol with systemic injection, intracutaneous, and implantation tests; the quality system complies with ISO 13485:2016 and utilizes controlled‑atmosphere packaging in Tyvek/polyester‑foil pouches. Published data for long‑term gamma‑sterilized fatigue at the upper 50 kGy dose remains limited; users are advised to verify RCF retention after radiation exposure through spin burst testing on production‑representative samples per internal SOP Q‑CX‑027.

    Free Quote

    Competitive ELTEX MED PP Homopolymer 100-MG25 prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618136850665 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618136850665

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Get A Free Quote Now
    Certification & Compliance
    More Introduction

    Introduced into medical device manufacturing workflows where cycle-time reduction and consistent release performance govern economic viability, ELTEX MED PP Homopolymer 100-MG25 is a high-flow polypropylene grade engineered for thin-wall injection moulding. The resin carries a nominal melt mass-flow rate of 25 g/10 min when tested per ISO 1133-1 at 230 °C under a 2.16 kg piston load, placing it at the upper end of the viscosity spectrum typical for medical homopolymers. The homopolymer backbone, devoid of comonomer interruptions, yields a crystalline morphology that produces elevated flexural modulus and surface hardness values compared to random copolymer grades of equivalent fluidity, while the narrow molecular weight distribution engineered into the polymerisation sequence limits shear-thinning variance during high-speed filling. Confirmation of batch-to-batch lot consistency is maintained through statistical process control charts tied to ISO 1873-2 designatory properties, ensuring that cavity-to-cavity weight repeatability falls within a ±0.15 % coefficient of variation on multi-cavity tools with up to 128 impressions. Pre-compounding with hindered phenolic antioxidant packages and acid scavengers, executed during pelletisation, provides a baseline thermo-oxidative stability sufficient to withstand multiple re-grind passes at up to 30 % regranulate content when processed within the recommended melt-temperature envelope.

    Parts moulded from this grade find primary application in disposable laboratory consumables, pipette tips, centrifuge tubes, and syringe barrels where annular wall sections routinely drop below 0.4 mm and the dimensional accuracy of a Luer taper must be held across millions of cycles without flash or short-shot defects. The absence of slip agents in the standard formulation removes a variable that can interfere with silicone oil coating adhesion in prefillable syringe systems, while the homopolymer’s intrinsically low organic extractable profile—quantified as total non-volatile residue below 5.0 mg/dm² under ISO 10993-12 aqueous extraction conditions—aligns with the clean-material philosophy required for ISO Class 8 cleanroom manufacturing suites.

    Why Does Melt Flow Rate Dictate Cycle Time in High-Cavitation Moulds?

    When a polymer melt is forced through narrow gates at shear rates exceeding 10⁴ s⁻¹, the pressure drop across the runner system becomes the rate-limiting step in achieving a complete packing phase before the gate freeze-off arrests material conveyance. In a 64-cavity syringe mould running on an Engel e-victory 170 with a 30 mm diameter, 22:1 L/D reciprocating screw, the melt-front velocity required to fill all impressions before the thermal skin reaches no-flow thickness demands a resin that produces minimal back-pressure accumulation at the nozzle tip yet retains sufficient hot-creep resistance to avoid stringing during sprue break. ELTEX MED PP Homopolymer 100-MG25, through its controlled rheology architecture, exhibits a power-law index that remains relatively stable between 220 °C and 250 °C, meaning that operators can raise the barrel temperature setpoints—screw zone 210 °C, compression zone 230 °C, metering zone 245 °C, and nozzle at 255 °C—without inducing a runaway lowering of melt viscosity that would compromise back-flow sealing against the non-return valve. The reduced injection pressure demand, typically 15–20 % below that required by a 12 g/10 min homopolymer in the same tool, permits the use of lower clamping forces per cavity and consequently extends tool life on hardened steel inserts by limiting parting-line wear. Degraded volume due to residence-time distribution in the hot runner manifold is contained by purging after any interruption exceeding 3 min, a discipline enforced by shift logs auditable under ISO 13485 Device Master Record protocols.

    Pre-conditioning of the granules is mandatory when storage relative humidity exceeds 60 %; a desiccant dryer set to 80 °C for 2 hours consistently reduces surface moisture to below 0.03 % by weight, as verified via Karl Fischer coulometry, preventing hydrolysis-induced void formation at the sprue bush during the decompression stroke. Direct-gated tooling configurations show less sensitivity to trace moisture than submarine-gated layouts, yet the practice of preventative drying is maintained across all production cells to eliminate the risk of splay defects migrating into the gate-land area where optical clarity under transmitted light is a cosmetic acceptance criterion per ANSI/AAMI ST72 visual inspection guidelines.

    Gamma Sterilization and Long-Term Colour Hold

    Exposure to gamma irradiation at standard sterilisation doses initiates a cascade of free-radical reactions in polypropylene that leads to chain scission, terminal double-bond formation, and yellowing through conjugated chromophore accumulation. Unstabilised homopolymer grades can surpass a yellowness index of 15 after a single 25 kGy dose, making visual sorting of filled opioid syringes impossible under hospital lighting. The stabilisation package incorporated into 100-MG25 is formulated to quench radiolytic peroxides before they propagate into visible discolouration. Accelerated ageing studies conducted in air atmosphere and tracked against ASTM D1925 colour coordinates show a delta YI of less than 4.0 units after cumulative doses totalling 50 kGy administered in 10 kGy increments with 24-hour inter-sterilisation intervals. This characteristic becomes operationally relevant when dual sterilisation—first at the component supplier, second as a terminal treatment—is required by a pharmaceutical sponsor’s sterile claim strategy. The physical property retention ratio, expressed as elongation at break after irradiation divided by elongation at break before irradiation, remains above 0.85 when measured on ISO 527-2/1A specimens, an empirical boundary below which snap-failure during drop testing of an assembled syringe can no longer be excluded at a 95 % confidence level.

    Direct comparison with standard reactor-grade homopolymer (MFI 25) that omits the radiostabilisation masterbatch reveals the difference within 48 hours post-irradiation, whereas oxidative annealing over 14 days under nitrogen purge partially reverses the chromophore build-up in unstabilised controls but does not close the gap. Hence, when colour-stable medical components are specified on the procurement drawing, the grade designation must include the radiopaque additive package identifier, otherwise incoming inspection against ISO 7724-3 spectrophotometric acceptance limits will fail the shipment.

    If Extractables Control Is Non-Negotiable for Parenteral Drug Delivery Systems

    Regulatory submissions for primary containers that involve chronic drug contact require a chemical characterisation report that identifies, quantifies, and toxicologically assesses each organic compound migrating from the plastic into simulated extraction media. ELTEX MED PP Homopolymer 100-MG25, when subjected to exhaustive extraction protocols aligned with ICH Q3D and ISO 10993-18, demonstrates a total extractable profile where the dominant species—saturated and unsaturated oligomeric telechelic chains in the C₁₂–C₂₈ range—fall below the analytical evaluation threshold of 5 µg/g in 50 % ethanol/water refluxed for 8 hours, as resolved by GC-MS with electron-impact ionisation. Metal traces arising from Ziegler-Natta catalyst residues are controlled to sub-1 ppm levels for aluminium, titanium, and magnesium, verified by inductively coupled plasma optical emission spectroscopy after microwave-assisted acid digestion in compliance with Ph. Eur. 3.1.6 monographs for polypropylene materials for containers and tubing.

    Summary of global pharmacopoeial and food-contact requirements applicable to the grade
    Standard / RegulationTesting contextPerformance requirement
    USP <661> (Plastic Packaging Systems)Extraction in purified water at 70 °C for 24 hNon-volatile residue ≤ 5 mg per 100 cm²; heavy metals ≤ 1 ppm
    FDA 21 CFR 177.1520General olefin polymer specificationMax. soluble fraction in n-hexane ≤ 6.4 % at 50 °C
    Ph. Eur. 3.1.3 (Polyolefins)Plastic containers for aqueous parenteral infusionsReducing substances, acidity/alkalinity, clarity of extract
    ISO 10993-10Skin sensitisation (closed patch, Guinea pig maximisation)No erythema or oedema above Grade 1
    REACH (EC) 1907/2006Candidate List SVHC screeningAbsence of listed phthalates, organotins, and halogenated flame retardants
    RoHS 2011/65/EUElectrical medical device housingsPb, Hg, Cd, Cr(VI) below homogeneous material limit

    The barrier against leachable nitrosamines—a concern when the polymer is heat-aged in the presence of nitrogen-containing disinfectants—is maintained through the exclusion of secondary amine-based antistatic additives from the compounding recipe. Users seeking to incorporate external lubricants for demoulding on intricate core pulls must verify that the selected additive (e.g., erucamide or oleamide) does not form N-nitrosated derivatives under the acidic pH of certain biopharmaceutical formulations; compatibility testing with the dosage form at 40 °C and 75 % relative humidity over 6 months according to ICH Q1A stability protocol is the accepted verification pathway. Published data for this specific lubricant-grade interaction in the 100-MG25 matrix remains limited, necessitating a case-by-case extractables study prior to the Design Freeze milestone.

    Mechanical Profile Compared to Random Copolymer Alternatives

    A common substitution pathway in diagnostic cuvette platforms involves replacing a lower-cost random copolymer (MFI 25, ethylene content 3–4 %) with the homopolymer 100-MG25 to gain the higher light transmission permitted by the reduced interfacial haze at the amorphous-crystalline boundary. The accompanying mechanical property shift, however, must be evaluated against the operating force envelope of automated pipetting robotics. The table below captures side-by-side values derived from specimens injection-moulded under identical conditions on an Arburg Allrounder 470 A with a 35 mm screw and conditioned for 40 hours at 23 °C/50 % RH.

    Comparative mechanical data (typical values, not specification limits)
    PropertyTest methodELTEX MED PP Homopolymer 100-MG25Random Copolymer (MFI 25, Et ~3.5 %)
    Tensile modulusISO 527-2/1A/11550 MPa ± 801150 MPa ± 65
    Tensile yield stressISO 527-2/1A/5035 MPa27 MPa
    Flexural modulusISO 1781450 MPa1050 MPa
    Charpy notched impact (+23 °C)ISO 179-1/1eA3.0 kJ/m²6.5 kJ/m²
    Charpy notched impact (0 °C)ISO 179-1/1eA1.8 kJ/m²4.2 kJ/m²
    HDT B (0.45 MPa)ISO 75-2/B90 °C75 °C

    The notch sensitivity difference at reduced temperatures dictates that snap-fit closures designed for the ductile copolymer must be revalidated by instrumented puncture impact testing (ISO 6603-2) with the homopolymer, particularly when cold-chain distribution at -20 °C is a logistical requirement. Moulding trials on in-mould labelled containers have also shown that the faster crystallisation onset of the homopolymer—detected by differential scanning calorimetry at a peak temperature 4–6 °C higher than that of the copolymer under a cooling rate of 20 K/min—demands a corresponding increase in holding pressure time by 0.3–0.5 seconds to offset shrinkage anisotropy before the gate seal point, otherwise cavity-specific ovality exceeds the 0.1 mm circularity tolerance called out on the engineering drawing.

    Top